Virpax Pharmaceuticals, Inc. (VRPX) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Current assets
Cash
Prepaid expenses and other current assets	1.1	1.5	0.7	3.1	3.3	3.9	2.7	1.6
Total current assets	16.0	18.5	19.7	23.6	29.4	34.7	39.6	43.3
Total assets	16.0	18.5	19.7	23.6	29.4	34.7	39.6	43.3

Current liabilities
Accounts payable and accrued expenses	1.6	1.3	3.1	4.2	2.5	2.2	2.1	1.8
Estimated litigation liability	2.0	2.0
Total current liabilities	3.6	3.3	3.1	4.2	2.5	2.2	2.1	1.8
Total liabilities	3.6	3.3	3.1	4.2	2.5	2.2	2.1	1.8

Commitments and contingencies
Stockholders’ equity
Preferred stock, par value $0.00001, 10,000,000 shares authorized; no shares issued and outstanding as of both June 30, 2023 and December 31, 2022
Common stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	61.3	61.1	60.9	60.8	60.6	60.4	60.2	60.0
Accumulated deficit	-49.0	-45.9	-44.4	-41.4	-33.7	-27.8	-22.7	-18.6
Total stockholders’ equity	12.3	15.2	16.6	19.4	26.9	32.6	37.5	41.5
Total liabilities and stockholders’ equity	16.0	18.5	19.7	23.6	29.4	34.7	39.6	43.3